Sanofi Pasteur to accelerate vaccine development with VaxDesign acquisiton
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur, Sanofi-Aventis's vaccines division, is to pay $55 million to acquire the private US biotech company VaxDesign, which claims its technology can accelerate the development of vaccines "by several years".